Compare DDS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DDS | RGEN |
|---|---|---|
| Founded | 1938 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.5B | 8.2B |
| IPO Year | N/A | N/A |
| Metric | DDS | RGEN |
|---|---|---|
| Price | $648.91 | $148.94 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $511.33 | $177.18 |
| AVG Volume (30 Days) | 139.4K | ★ 668.8K |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | ★ 4.86% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 36.93 | 0.03 |
| Revenue | ★ $6,625,563,000.00 | $707,890,000.00 |
| Revenue This Year | $1.07 | $17.86 |
| Revenue Next Year | $0.57 | $12.44 |
| P/E Ratio | ★ $17.37 | $4,865.68 |
| Revenue Growth | N/A | ★ 11.74 |
| 52 Week Low | $282.24 | $102.97 |
| 52 Week High | $741.98 | $175.77 |
| Indicator | DDS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 32.42 |
| Support Level | $600.86 | $145.01 |
| Resistance Level | $627.26 | $160.88 |
| Average True Range (ATR) | 26.11 | 6.98 |
| MACD | -0.47 | -1.99 |
| Stochastic Oscillator | 57.17 | 11.69 |
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.